Analysis from the Women's Health Initiative has found that women who took the bone saving drugs called bisphosphonates had fewer invasive breast cancers than women who didn't take the meds. The analysis of more than 150,000 women found that those who were taking Fosamax had 32 percent fewer cases of invasive breast cancer. Experts say further studies are needed, but they suggest that the finding may affect a woman's decision about whether she takes a bisphosphonate or not.
I was concerned to learn that individuals who survive gastric cancer are especially at risk for osteoporosis. According to research... Read more »
Lila de Tantillo, an expert from our partner site OsteoporosisConnection.com, discusses osteoporosis as a side effect of breast cancer... Read more »
For the past few years, most physicians have routinely treated osteoporosis in the same manner. The most commonly used medication class is... Read more »
When you’re diagnosed with breast cancer, it becomes the Big Gorilla in the corner, healthwise. The sore throat, head cold, or heartburn... Read more »
You’re feeling fit, healthy, enjoying life. Sure, you’re not 20 years old anymore; maybe you can’t pedal uphill as fast, run as far,... Read more »
This is a study to see how well the drug Zometa works compared to calcium and vitamin D alone in preventing osteoporosis and bone fractures in men... Read more »
Two new studies find no evidence that bisphosphonate drugs raise the risk of esophageal cancer. These results counter FDA reports of 23 patients who... Read more »
People who develop osteoporosis at younger ages may have a higher risk of certain cancers, researchers say. The scientists also found that people who... Read more »
A test known as the "virtual colonoscopy" can identify more than colon polyps--it may also identify osteoporosis. The non-invasive procedure uses CT... Read more »
This is a study to see how well Zometa works compared to a placebo in preventing osteoporosis and bone fractures in patients with nonmetastatic... Read more »